ArticlePediatric blood & cancer2011

Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group.

Brigitte C Widemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.